Director, Patient-Centered Outcomes—Oncology Evidence

Jazz Pharmaceuticals, Inc.; Saffron Walden; On-site; GBP 158,000 - 237,000; Full time

Benefits offered by this job

Discretionary bonuses

Equity grants

Medical/dental/vision insurance

401k retirement plan

Flexible vacation

Job summary

Jazz Pharmaceuticals, Inc. seeks a Director of Patient-Centered Outcomes to lead patient-focused evidence programs for oncology launches and lifecycle initiatives.

The role shapes COA, PED, and PRO strategies across global programs, guiding regulatory interactions and directing measurement strategies aligned with product profiles. The candidate will design endpoints for labeling, oversee qualitative and psychometric validation, and drive digital health innovations in real-time outcome capture.

Qualifications

• 8-10+ years in Patient-Centered Outcomes, COAs, PROs, or HEOR.
• Oncology launches COA/PRO strategies.
• Regulatory submissions and health authority engagement.

Responsibilities

• Lead Neuro-Oncology launch efforts with patient-focused evidence packages.
• Design patient-centered strategies for oncology launches and lifecycle expansions.
• Collaborate with early development teams to establish COA roadmaps.

Skills

Patient-Centered Outcomes

Oncology COA/PRO

Regulatory submissions

Psychometrics

Payer & HTA

Global eCOA/ePRO

Communication

Education

Master's or Doctoral degree

Doctoral degree preferred

Job description

Jazz Pharmaceuticals, Inc. seeks a Director of Patient-Centered Outcomes to lead patient-focused evidence programs for oncology launches and lifecycle initiatives.

The role shapes COA, PED, and PRO strategies across global programs, guiding regulatory interactions and directing measurement strategies aligned with product profiles. The candidate will design endpoints for labeling, oversee qualitative and psychometric validation, and drive digital health innovations in real-time outcome capture.